The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement

Dear Colleagues,

Nowadays, the field of pharmacogenomics has seen remarkable progress, and it is expected that further advancements have occurred up to the present moment. Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, has increasingly gained prominence in personalized medicine. Recent developments include the identification of new genetic markers associated with drug metabolism, efficacy, and adverse reactions. The integration of next-generation sequencing technologies has allowed for more comprehensive genomic profiling, enabling healthcare professionals to tailor drug prescriptions based on an individual's genetic profile. Additionally, collaborative efforts between researchers, pharmaceutical companies, and healthcare providers have led to the development of guidelines and databases that facilitate the interpretation of genetic variations in the context of drug response. The ongoing progress in pharmacogenomics holds promise for optimizing drug therapy, minimizing adverse effects, and improving overall patient outcomes.

This Special Issue aims to gather cutting-edge research, innovative methodologies, and insightful perspectives that contribute to the understanding and advancement of pharmacogenetics, strategies for preventing drug toxicity, and methods for enhancing drug efficacy. We believe that your expertise in [mention the specific area of expertise or contribution] would significantly enrich the content of this Special Issue.

We look forward to receiving your valuable contribution to this Special Issue. Both research article Reviews are welcomed, we aim to be a comprehensive and influential compilation of research in the field.

Dr. Pura Ballester
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pharmacogenetics
• drug toxicity prevention
• efficacy enhancement
• pharmaceutical research
• precision medicine
• therapeutic optimization